SMAD4 and neoplasm: Corroborating a potentially tumor-suppressive versus tumor-promoting function of SMAD4 in the liver versus lungs, 69% of cases with recurrent liver metastases lacked SMAD4 expression, in contrast to 50% of concurrent and 33% of isolated lung metastases (Extended Data Fig. 2i).